Mollugo pentaphylla: New nutraceutical use as antidiabetic

Abstract

Nutraceuticals are the emerging era in the treatment of diabetes mellitus, one of the seriously problematic due to leading the causes of death in all over the world. The newer anti-hyperglycemic drugs continue searching because the existing synthetic drugs have several limitations. Traditional medicinal plants are used in the treatment of diabetes mellitus more than a century, but only a few of these have proofed their safe and efficacious. The aim of this review article is focused Mollugo pentaphylla one of the medicinal plants used for antioxidant activities. It contains several kinds of alkaloids, flavonoids, saponins, tannin, diterpenes, triterpenoids, glycosides and phenols. Many researchers have evaluated that these phytochemical substances have the major impact on diabetes mellitus. This review focuses on the hypoglycemic activity of this plant and clears that it has the potential to be considered as a candidate for preparing the new treatment of diabetes mellitus.